Related Experiment Video
Updated: Mar 6, 2026

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients
Published on: June 24, 2019
Biological Activity of Masked Endotoxin
Harald Schwarz1, Jan Gornicec1, Theresa Neuper1
1Department of Molecular Biology, University of Salzburg, Salzburg, Austria.
Low endotoxin recovery (LER) prevents accurate detection of lipopolysaccharide (LPS) in medical products. Masked LPS remains biologically active, potentially triggering dangerous immune responses.
Area of Science:
- Biochemistry
- Immunology
- Analytical Chemistry
Background:
- Low endotoxin recovery (LER) is a phenomenon where limulus amebocyte lysate (LAL) assays fail to detect lipopolysaccharide (LPS).
- This failure is attributed to a masking effect caused by common buffer components like chelators and detergents in medical products and recombinant proteins.
Purpose of the Study:
- To investigate the masking capacities of various buffer formulations on endotoxin detection.
- To determine if endotoxin affected by LER retains biological activity.
Main Methods:
- Testing naturally occurring and standard control endotoxin with different buffer formulations.
- Utilizing Factor C-based assays and a cell-based TLR4-NF-κB-luciferase reporter gene assay to assess endotoxin detection.
- Analyzing pro-inflammatory cytokine and surface marker expression in primary human monocytes exposed to masked LPS.
Main Results:
- Both naturally occurring and standard endotoxin were susceptible to the LER masking effect.
- Masked endotoxin was undetectable by Factor C assays but detectable by the cell-based reporter assay.
- Masked LPS induced pro-inflammatory responses in human monocytes even at low concentrations.
Conclusions:
- Masked lipopolysaccharide (LPS) retains significant biological activity and can potentely trigger immune responses.
- The presence of masked LPS in pharmaceutical products poses a potential health risk due to its immunogenicity.
- LER can compromise experimental results by masking endotoxin, necessitating careful buffer selection and validation.
More Related Videos
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020